Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors.
作者信息
Chapman Daniel, Judge Parminder K, Sardell Rebecca J, Staplin Natalie, Arnold Thomas, Zhu Doreen, Ng Sarah, Moffat Stewart, Landray Martin J, Baigent Colin, Hill Michael, Haynes Richard, Clark Sarah, Herrington William G
机构信息
Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
出版信息
Kidney Int. 2023 Apr;103(4):787-790. doi: 10.1016/j.kint.2022.12.027. Epub 2023 Feb 2.
Abstract
摘要
相似文献
1
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors.
Kidney Int. 2023 Apr;103(4):787-790. doi: 10.1016/j.kint.2022.12.027. Epub 2023 Feb 2.
2
A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
Endocrine. 2017 Aug;57(2):272-279. doi: 10.1007/s12020-017-1341-2. Epub 2017 Jun 7.
3
Can a genetic mutation associated with glycosuria teach us about the action of sodium-glucose cotransporter-2 inhibitors?
Cardiovasc Res. 2023 Nov 15;119(14):2385-2386. doi: 10.1093/cvr/cvad142.
4
5
Renal protective effect and safety of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease and type 2 diabetes mellitus: a network meta-analysis and systematic review.
Int Urol Nephrol. 2022 Sep;54(9):2305-2316. doi: 10.1007/s11255-022-03117-4. Epub 2022 Feb 8.
6
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Urine Albumin to Creatinine Ratio in Type 2 Diabetes Mellitus Patients and Medication Care.
J Diabetes Res. 2022 Jul 20;2022:5854200. doi: 10.1155/2022/5854200. eCollection 2022.
7
Factors that predict glycaemic response to sodium-glucose linked transporter (SGLT) inhibitors.
Intern Med J. 2021 Apr;51(4):515-519. doi: 10.1111/imj.14805.
8
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease.
Diabetes Obes Metab. 2024 Apr;26(4):1273-1281. doi: 10.1111/dom.15427. Epub 2024 Jan 8.
9
Hormonal, Metabolic and Hemodynamic Adaptations to Glycosuria in Type 2 Diabetes Patients Treated with Sodium-Glucose Co-Transporter Inhibitors.
Curr Diabetes Rev. 2019;15(4):314-327. doi: 10.2174/1573399814666180813124645.
10
A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor.
Diabetes Metab J. 2019 Dec;43(6):898-905. doi: 10.4093/dmj.2018.0257. Epub 2019 Jun 14.
本文引用的文献
1
Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials.
EClinicalMedicine. 2021 Oct 26;41:101163. doi: 10.1016/j.eclinm.2021.101163. eCollection 2021 Nov.
2
Dapagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.
3
Clinical and Analytical Impact of Moving from Jaffe to Enzymatic Serum Creatinine Methodology.
J Appl Lab Med. 2020 Jul 1;5(4):631-642. doi: 10.1093/jalm/jfaa053.
4
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.
Lancet Diabetes Endocrinol. 2019 Feb;7(2):128-139. doi: 10.1016/S2213-8587(18)30314-0. Epub 2019 Jan 8.
5
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.
Lancet Diabetes Endocrinol. 2017 Jun;5(6):431-437. doi: 10.1016/S2213-8587(17)30104-3. Epub 2017 Mar 30.
6
The effect of extremely high glucose concentrations on 21 routine chemistry and thyroid Abbott assays: interference study.
Biochem Med (Zagreb). 2016;26(1):53-60. doi: 10.11613/BM.2016.004.
7
Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis.
J Am Soc Nephrol. 2015 Aug;26(8):2055-64. doi: 10.1681/ASN.2014070688. Epub 2014 Nov 24.
8
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.
Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.
Zotero 插件